Originally published by State House News Service on November 17, 2021
In one of the largest industries in Massachusetts, gender diversity on the boards of biopharmaceutical companies has improved significantly over the past four years, but women have not made the same progress advancing into senior executive roles and Black and Latinx workers continue to be underrepresented in the workforce, according to a new industry survey.